Costimulation: Critical pathways in the immunologic regulation of asthma

Current Allergy and Asthma Reports

Volumn 5, Issue 2, 2005, Pages 149-154

  Bellou, Abdelouahab ^a   Finn, Patricia W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B AND T LYMPHOCYTE ATTENUATOR PROTEIN; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; PROTEIN PROGRAMMED DEATH 1; SIGNAL PEPTIDE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ALLERGY; ANTIGEN PRESENTATION; ASTHMA; CELLULAR IMMUNITY; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 14744294833     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0089-6     Document Type: Review

References (61)

1. Kuipers H, Lambrecht BN: The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol 2004, 16:702-708.
2. Lambrecht BN, Hammad H: Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 2003, 3: 94-1003.
3. Lambrecht BN: The dendritic cell in allergic airway diseases: a new player to the game. Clin Exp Allergy 2001, 31:206-218.
4. Coyle AJ, Gutierrez-Ramos JC: The role of ICOS and other costimulatory molecules in allergy and asthma. Springer Semin Immunopathol 2004, 25:349-359.
5. Linsley PS, Brady W, Urnes M, et al.: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991, 174:561-569.
6. Lanier LL, O'Fallon S, Somoza C, et al.: CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995, 154:97-105.
7. Jenkins MK, Taylor PS, Norton SD, Urdahl KB: CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991, 147:2461-2466.
8. Sharpe AH, Freeman GJ: The B7-CD28 superfamily. Nat Rev Immunol 2002, 2:116-126.
9. Lucas PJ, Negishi I, Nakayama K, et al.: Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J Immunol 1995, 154: 757-5768.
10. Boise LH, Minn AJ, Noel PJ, et al.: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995, 3:87-98.
11. Linsley PS, Bradshaw J, Greene J, et al.: Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996, 4:535-543.
12. Chambers CA, Kuhns MS, Egen JG, Allison JP: CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 2001, 19:565-594.
13. Finn PW, He H, Wang Y, et al.: Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability. J Immunol 1997, 158:4074-4081.
14. Perkins DL, Wang Z, Donovan CE, et al.: Regulation of CTLA4 expression during T cell activation. J Immunol 1996, 156:4154-4159.
15. Greenwald RJ, Oosterwegel MA, van der Woude D, et al.: CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol 2002, 32:366-373.
16. Mandelbrot DA, McAdam AJ, Sharpe AH: B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med 1999, 189:435-440.
17. Greenwald RJ, Boussiotis VA, Lorsbach RB, et al.: CTLA-4 regulates induction of anergy in vivo. Immunity 2001, 14:145-155.
18. Perez VL, Van Parijs L, Biuckians A, et al.: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997, 6:411-417.
19. Perrin PJ, Maldonado JH, Davis TA, et al.: CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol 1996, 157: 333-1336.
20. Karandikar NJ, Vanderlugt CL, Bluestone JA, Miller SD: Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. J Neuroimmunol 1998, 89:10-18.
21. Freeman GJ, Borriello F, Hodes RJ, et al.: Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med 1993, 178:2185-2192.
22. Sethna MP, van Parijs L, Sharpe AH, et al.: A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1994, 1:415-421.
23. Beier KC, Hutloff A, Dittrich AM, et al.: Induction, binding specificity and function of human ICOS. Eur J Immunol 2000, 30:3707-3717.
24. Mages HW, Hutloff A, Heuck C, et al.: Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol 2000, 30:1040.
25. Hutloff A, Dittrich AM, Beier KC, et al.: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999, 397:263-266.
26. Ling V, Wu PW, Finnerty HF, et al.: Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol 2000, 164:1653-1657.
27. Aicher A, Hayden-Ledbetter M, Brady WA, et al.: Characterization of human inducible costimulator ligand expression and function. J Immunol 2000, 164:4689-4696.
28. Coyle AJ, Lehar S, Lloyd C, et al.: The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000, 13:95-105.
29. McAdam AJ, Chang TT, Lumelsky AE, et al.: Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol 2000, 165:5035-5040.
30. Kopf M, Coyle AJ, Schmitz N, et al.: Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med 2000, 192: 3-61.
31. Ishida Y, Agata Y, Shibahara K, Honjo T: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992, 11: 887-3895.
32. Latchman Y, Wood CR, Chernova T, et al.: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001, 2:261-268.
33. Nishimura H, Nose M, Hiai H, et al.: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11: 41-151.
34. Walunas TL, Lenschow DJ, Bakker O, et al.: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994, 1:405-413.
35. Watanabe N, Gavrieli M, Sedy JR, et al.: BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 2003, 4:670-679.
36. Vieira PL, Wassink L, Smith LM, et al.: ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cells. Eur J Immunol 2004, 34:1282-1290.
37. Tsuyuki S, Tsuyuki J, Einsle K, et al.: Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997, 185:1671-1679.
38. Gonzalo JA, Tian J, Delaney T, et al.: ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat Immunol 2001, 2:597-604.
39. van Rijt LS, Vos N, Willart M, et al.: Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. J Allergy Clin Immunol 2004, 114:166-173.
40. Croft M: Co-stimulatory members of the TNFR family: keys to effective T-cell immunity. Nat Rev Immunol 2003, 3: 09-620.
41. Croft M: Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev 2003, 14:265-273.
42. Salek-Ardakani S, Song J, Halteman BS, et al.: OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 2003, 198:315-324.
43. Arestides RS, He H, Westlake RM, et al.: Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002, 32: 874-2880.
44. Mottet C, Yhlig HH, Powrie F: Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003, 170: 939-3943.
45. McHugh RS, Shevach EM: The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol 2002, 110:693-702.
46. Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
47. Zhai Y, Kupiec-Weglinski JW: What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 1999, 11:497-503.
48. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
49. Umetsu DT, Akbari O, Dekruyff RH: Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol 2003, 112:480-487.
50. Akbari O, Freeman GJ, Meyer EH, et al.: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002, 8:1024-1032.
51. Medzhitov R, Janeway CA Jr: Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997, 9:4-9.
52. Velasco G, Campo M, Manrique OJ, et al.: Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 2004, E pub ahead of print.
53. von Mutius E: Pro: the increase in asthma can be ascribed to cleanliness. Am J Respir Crit Care Med 2001, 164: 106-1107.
54. Bellou AS, Ting B, Finn L: Toll receptors modulated allergic responses: interaction with dendritic cells, T cells and mast cells. Curr Opin Allergy Clin Immunol 2003, 3:487-494.
55. Schaub B, Bellou A, Gibbons FK, et al.: TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells. J Interferon Cytokine Res 2004, 24:543-552.
56. Krinzman SJ, De Sanctis GT, Cernadas M, et al.: T cell activation in a murine model of asthma. Am J Physiol 1996, 271:L476-L483.
57. Krinzman SJ, De Sanctis GT, Cernadas M, et al.: Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 1996, 98:2693-2699.
58. Mark DA, Donovan CE, De Sanctis GT, et al.: Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation. Int Immunol 1998, 10:1647-1655.
59. Mark DA, Donovan CE, De Sanctis GT, et al.: B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. Am J Respir Cell Mol Biol 2000, 22:265-271.
60. Holgate ST: Genetic common ground between allergic and autoimmune disease: The role of cytotoxic T-lymphocyte antigen 4. J Allergy Clin Immunol 2004, 114:277-279.
61. Sayegh MH, Akalin E, Hancock WW, et al.: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995, 181:1869-1874.